Albany Molecular Research (AMRI) Misses Q1 EPS by 7c
Tweet
Share
E-mailGet Alerts AMRI Hot Sheet
Price: $21.74 --0%
Financial Fact:
Loss from operations: -15.66M
Today's EPS Names:
FRSB, DGICA, UXIN, More
Financial Fact:
Loss from operations: -15.66M
Today's EPS Names:
FRSB, DGICA, UXIN, More
Join SI Premium – FREE
Albany Molecular Research (NASDAQ: AMRI) reported Q1 EPS of $0.16, $0.07 worse than the analyst estimate of $0.23. Revenue for the quarter came in at $51 million versus the consensus estimate of $62.19 million.
For earnings history and earnings-related data on Albany Molecular Research (AMRI) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Gilead Sciences (GILD) Misses Q1 EPS by 288c
- Skechers USA (SKX) Tops Q1 EPS by 23c, Beats on Revenue; Offers FY24 Guidance
- Gaming and Leisure Properties (GLPI) Misses Q1 EPS by 6c
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
